SACCHI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 11.143
EU - Europa 6.959
AS - Asia 4.585
SA - Sud America 678
Continente sconosciuto - Info sul continente non disponibili 168
AF - Africa 73
OC - Oceania 44
Totale 23.650
Nazione #
US - Stati Uniti d'America 10.881
IT - Italia 3.632
SG - Singapore 1.435
CN - Cina 1.084
UA - Ucraina 1.023
VN - Vietnam 647
BR - Brasile 579
SE - Svezia 556
TR - Turchia 548
HK - Hong Kong 514
FI - Finlandia 321
DE - Germania 294
IE - Irlanda 267
GB - Regno Unito 236
FR - Francia 209
RU - Federazione Russa 160
CA - Canada 148
IN - India 78
MX - Messico 67
JP - Giappone 62
BD - Bangladesh 57
CZ - Repubblica Ceca 49
AU - Australia 41
ES - Italia 32
NL - Olanda 31
AR - Argentina 30
PL - Polonia 29
ZA - Sudafrica 29
BE - Belgio 27
AT - Austria 24
IQ - Iraq 24
EC - Ecuador 22
PK - Pakistan 22
CO - Colombia 19
EU - Europa 18
ID - Indonesia 18
LT - Lituania 14
CH - Svizzera 13
NG - Nigeria 13
AE - Emirati Arabi Uniti 10
IL - Israele 10
CL - Cile 9
JM - Giamaica 9
JO - Giordania 8
AZ - Azerbaigian 7
KE - Kenya 7
MA - Marocco 7
MD - Moldavia 7
MY - Malesia 7
CR - Costa Rica 6
KR - Corea 6
NP - Nepal 6
SA - Arabia Saudita 6
VE - Venezuela 6
NI - Nicaragua 5
RO - Romania 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
GE - Georgia 4
KZ - Kazakistan 4
PY - Paraguay 4
AL - Albania 3
CU - Cuba 3
GR - Grecia 3
HU - Ungheria 3
MT - Malta 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
CI - Costa d'Avorio 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
Totale 23.482
Città #
Milan 2.443
Fairfield 966
San Jose 934
Ashburn 873
Jacksonville 804
Singapore 750
Chandler 698
Woodbridge 635
Hong Kong 509
Seattle 395
Wilmington 392
Houston 359
Como 353
Council Bluffs 324
Ann Arbor 318
Dearborn 302
Princeton 297
Nyköping 295
Beijing 291
Cambridge 286
Dublin 263
Izmir 263
Dallas 225
The Dalles 214
Boardman 184
Dong Ket 181
Rome 161
Lauterbourg 135
Chicago 120
New York 110
Ho Chi Minh City 107
Los Angeles 98
San Mateo 86
Helsinki 84
Hanoi 73
Orem 72
San Diego 69
Santa Clara 68
Toronto 66
Munich 64
Tokyo 56
Ogden 54
São Paulo 50
Guangzhou 44
Mexico City 40
Chennai 37
Hefei 36
Kocaeli 36
London 35
Washington 35
Varese 33
Denver 32
Nanjing 30
Brussels 27
Olomouc 27
Warsaw 27
Brooklyn 26
Phoenix 26
Montreal 24
Redmond 23
Kunming 22
Manchester 22
Poplar 22
Amsterdam 21
Atlanta 21
Düsseldorf 21
Frankfurt am Main 21
Shanghai 21
Brno 20
Johannesburg 19
Rio de Janeiro 19
San Francisco 19
Turku 19
Haiphong 18
Norwalk 17
Tianjin 17
Verona 17
Da Nang 16
Boston 15
Bursa 15
Ankara 14
Columbus 14
Hangzhou 14
Mumbai 14
Redwood City 14
Shenzhen 14
Vienna 14
Belo Horizonte 13
Nanchang 13
Nuremberg 13
Stockholm 13
Abuja 12
Changsha 12
Dhaka 12
Gavirate 12
Jinan 12
Brasília 11
Buffalo 10
Fuzhou 10
Wenzhou 10
Totale 16.198
Nome #
Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. 392
Evidence for the interaction of d-amino acid oxidase with pLG72 in a glial cell line. 283
Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs 279
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 265
Biosensors for D-amino acid detection 258
Structure-function relationships in human D-amino acid oxidase. 257
Effect of ligand binding on human D-amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment 250
Characterization of human DAAO variants potentially related to an increased risk of schizophrenia 241
Modulating D-amino acid oxidase substrate specificity: production of an enzyme for analytical determination of all D-amino acids by directed evolution 233
Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex. 227
Human d-amino acid oxidase: The inactive G183R variant 226
Characterization of human D-amino acid oxidase 225
A biosensor for all D-amino acids using evolved D-amino acid oxidase 224
Determination of D-amino acids using a D-amino acid oxidase biosensor with spectrophotometric and potentiometric detection 215
G72 primate-specific gene: a still enigmatic element in psychiatric disorders 215
Decreased free D-aspartate levels are linked to enhanced D-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients 215
D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy 212
Relevance of weak flavin binding in human D-amino acid oxidase 209
The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. 208
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity 208
Biochemical properties of human D-amino acid oxidase 208
Investigating the role of active site residues of Rhodotorula gracilis D-amino acid oxidase on its substrate specificity. 207
Catalytic properties of D-amino acid oxidase in cephalosporin C bioconversion: A comparison between proteins from different sources 207
Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line 207
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 205
Human D-Amino Acid Oxidase: Structure, Function, and Regulation 200
Active site and reaction mechanism of Rhodotorula gracilis D-amino acid oxidase: a crystallographic and site-directed mutagenesis approach 199
Elucidating the role of the pLG72 R30K substitution in schizophrenia susceptibility 199
Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction 198
Reduced D-serine levels in the nucleus accumbens of cocaine-treated rats hinder the induction of NMDA receptor-dependent synaptic plasticity 193
Optimization of glutaryl-7-aminocephalosporanic acid acylase expression in E.coli 190
High-Throughput Screening Strategy Identifies Allosteric, Covalent Human D-Amino Acid Oxidase Inhibitor 190
Is rat an appropriate animal model to study the involvement of d-serine catabolism in schizophrenia? insights from characterization of d-amino acid oxidase. 189
D-Serine and Glycine Differentially Control Neurotransmission during Visual Cortex Critical Period 189
Biochemical properties of human D-amino acid oxidase variants and their potential significance in pathologies 187
Active site of yeast D-amino acid oxidase: mutations and inferences 186
The Freshwater Cyanobacterium Leptolymbya sp. FP1: PSP Toxins detection and genetic identification 185
Active site and reaction mechanism of Rhodotorula gracilis D-amino acid oxidase:a crystallographic and site-directed mutagenesis approach 185
Expression in Escherichia coli and in vitro refolding of the human protein pLG72 185
The role of tyrosines 223 and 238 in Rhodotorula gracilis D-amino acid oxidase catalysis: Interpretation of double mutations 185
Role of tyrosine 238 in the active site of Rhodotorula gracilis D-amino acid oxidase - A site-directed mutagenesis study 183
Novel insights into renal d-amino acid oxidase accumulation: propiverine changes DAAO localization and peroxisomal size in vivo 183
Understanding renal nuclear protein accumulation: an in vitro approach to explain an in vivo phenomenon 180
Cellular studies on human D-aspartate oxidase 180
Active site of yeast D-amino acid oxidase:mutations and inferences 177
Physiological functions of D-amino acid oxidases: from yeast to humans. 176
The freshwater cyanobacterium Planktothrix SP.FP1: molecular identification and detection of paralytic shellfish poisoning toxins 176
Engineering the Properties of D-Amino Acid Oxidases by a Rational and a Directed Evolution Approach. 175
Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus 175
Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses 175
Deepening into the modulation of human D-amino acid oxidase 169
Properties and applications of microbial D-amino acid oxidases: Current state and perspectives 167
Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortex 167
Could D-serine serum levels be considered a biomarker in Alzheimer’s disease? 167
Role of human DAAO in D-serine metabolism: new insight 167
Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers 165
Characterization of human DAAO variants potentially related to an increased risk to schizophrenia 164
Modulation of the activity and stability of human D-amino acid oxidase by the interaction with small ligands. 164
... And now saxitoxin-producing cyanobacteria in Europe 163
Free D-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking D-aspartate oxidase activity 160
pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase - Effect on schizophrenia susceptibility 159
An antibody-based enzymatic therapy for cancer treatment: The selective localization of D-amino acid oxidase to EDA fibronectin 159
Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level. 158
Structural basis of D-aspartate oxidase properties 158
D-amino acid oxidase variants related to human pathologies 157
D-Serine metabolism in the brain: the role of D-amino acid oxidase 155
Glycine oxidase from Bacillus subtilis: Role of Histidine 244 and Methionine 261. 154
Engineering the substrate specificity of D-amino-acid oxidase 152
Serum D-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker 152
Metabolism of the neuromodulator D-serine 149
Antimicrobial D-amino acid oxidase-derived peptides specify gut microbiota 149
Biochemical characterization of mouse D-aspartate oxidase 149
Evolution of novel enzyme specificities from a common scaffold 148
Yin and Yang in Post-Translational Modifications of Human D-Amino Acid Oxidase 148
Biocatalysis and biocatalyst production 147
Detection of D-amino acids by D-amino acid oxidase. 146
Characterization of the G183R inactive human D-amino acid oxidase variant 146
Toxic cyanobacterial blooms in lake Varese (Italy): a multidisciplinary approach 143
Structure and function of Rhodotorula gracilis D-amino acid oxidase. 1. Site-directed mutagenesis of tyrosines 223 and 238 142
Insight into pLG72 and D-amino acid oxidase interaction 141
On the mechanism of Rhodotorula gracilis D-amino acid oxidase: role of the active site serine 335 140
pLG72-mediated modulation of hDAAO functionality: an intriguing issue 140
DNA methylation landscape of the genes regulating D-serine and D-aspartate metabolism in post-mortem brain from controls and subjects with schizophrenia 140
Characterization of human D-amino acid oxidase, a flavoenzyme involved in neurotransmission regulation 139
Engineering the substrate specificity of D-amino acid oxidase: a rational design approach 137
Role of the highly conserved Tyr223 and Tyr238 of yeast D-amino acid oxidase 137
Role of the highly conserved Tyr223 and Tyr238 of yeast D-amino acid oxidase 135
Investigating the molecular basis of schizophrenia: the effect of pLG72 interaction on the functionality of human D-amino acid oxidase 134
Structure and function of Rhodothorula gracilis D-amino acid oxidase. 1. Site-directed mutagenesis of tyrosine 223 and 238 134
Examination of pLG72 and D-Amino Acid Oxidase interaction as molecular basis of Schizophrenia. 133
Combinatorial and computational challenges to design the substrate specificity of D-amino acid oxidase 132
Engineering the substrate specificity of D-amino acid oxidase: a directed evolution approach 131
Enzyme factory: engineering of new biocatalysts strating from a common scaffold. 131
Biochemical Properties and Physiological Functions of pLG72: Twenty Years of Investigations 128
In vivo studies on the D-amino acid oxidase-pLG72 interaction in human brain 128
Engineering a new D-amino acid oxidase: an evoluted enzyme and its applications 127
Human D-aspartate Oxidase: A Key Player in D-aspartate Metabolism 126
Engineering the substrate specificity of D-amino acid oxidase by rational and irrational design 125
Investigating D-Amino Acid Oxidase and pLG72 as potential targets of the antipsychotic drug chlorpromazine. 125
Novel drugs for schizophrenia treatment: the mechanism of human D-amino acid oxidase inhibition 125
Totale 17.828
Categoria #
all - tutte 100.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.268 0 197 101 77 101 36 94 107 72 179 120 184
2022/20231.898 170 89 153 213 154 441 7 240 253 76 47 55
2023/20243.695 592 590 630 653 720 219 15 48 93 31 17 87
2024/20252.594 14 46 387 91 140 163 140 229 310 242 280 552
2025/20265.897 410 289 256 788 607 385 1.179 366 677 484 253 203
2026/2027411 176 235 0 0 0 0 0 0 0 0 0 0
Totale 23.650